Compounds > atenolol

atenolol and bevantolol

atenolol has been researched along with bevantolol in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (63.64)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (36.36)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Arnaud, A; Bruguerolle, B; Philip-Joet, F; Saadjian, A	1
Fairhurst, GJ	1
Rauramaa, R; Salonen, JT; Salonen, R; Seppänen, K; Taskinen, E; Venäläinen, J	1
Iwasaki, S; Kizawa, Y; Nakagoshi, A; Takayanagi, I	1
Bowcock, SA; Camm, AJ; Cooke, ED; Maltz, MB; Smith, RE; Watkins, CJ	1
Dasgupta, P; Hains, AD; Lahiri, A; Lawrence, JD; Raftery, EB; Rodrigues, EA; Wilkinson, PR	1
Folgering, HT; Lammers, JW; van Herwaarden, CL	1
Horinouchi, T; Koike, K; Miwa, S; Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Tanaka, Y	1

Trials

6 trial(s) available for atenolol and bevantolol

Article	Year
Comparative study of the respiratory effects of two beta 1-selective blocking agents atenolol and bevantolol in asthmatic patients. European journal of clinical pharmacology, 1986, Volume: 30, Issue:1 Topics: Adrenergic beta-Antagonists; Adult; Asthma; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Fenoterol; Forced Expiratory Volume; Heart Rate; Humans; Male; Peak Expiratory Flow Rate; Propanolamines; Random Allocation; Respiration; Time Factors	1986
Comparison of bevantolol and atenolol for systemic hypertension. The American journal of cardiology, 1986, Nov-26, Volume: 58, Issue:12 Topics: Adrenergic beta-Antagonists; Atenolol; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Propanolamines; Random Allocation	1986
Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris. The American journal of cardiology, 1986, Nov-26, Volume: 58, Issue:12 Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Atenolol; Blood Pressure; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Insulin; Lipoproteins; Male; Middle Aged; Nitroglycerin; Propanolamines; Prostaglandins; Random Allocation	1986
Peripheral vascular effects of beta-adrenoceptor blockade: comparison of two agents. British journal of clinical pharmacology, 1987, Volume: 24, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Isoproterenol; Male; Propanolamines; Regional Blood Flow; Respiratory Function Tests; Vascular Resistance	1987
Comparison of bevantolol and atenolol in chronic stable angina. The American journal of cardiology, 1988, Jun-01, Volume: 61, Issue:15 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Propanolamines; Random Allocation	1988
Ventilatory effects of atenolol and bevantolol in asthma. Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:4 Topics: Administration, Oral; Adult; Asthma; Atenolol; Blood Pressure; Chromatography, High Pressure Liquid; Double-Blind Method; Drug Evaluation; Forced Expiratory Volume; Heart Rate; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Peak Expiratory Flow Rate; Physical Exertion; Propanolamines; Random Allocation; Respiration; Vital Capacity	1985

Other Studies

5 other study(ies) available for atenolol and bevantolol

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
(+/-)-1-[[2-(3,4-Dimethoxphenyl)ethyl]amino]-3-(3-methylphenoxy)-2- propanol hydrochloride (bevantolol, NC-1400) as a beta 1-selective adrenoceptor blocker with alpha 1-adrenoceptor blocking activity. General pharmacology, 1987, Volume: 18, Issue:1 Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Guinea Pigs; In Vitro Techniques; Labetalol; Male; Muscle Contraction; Muscle, Smooth; Propanolamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta	1987
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life sciences, 2007, Jul-12, Volume: 81, Issue:5 Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Male; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction	2007